Quest Diagnostics Change in Accounts Receivable 2010-2025 | DGX
Quest Diagnostics annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Quest Diagnostics change in accounts receivable for the quarter ending June 30, 2025 was $-0.115B, a 1.77% increase year-over-year.
- Quest Diagnostics change in accounts receivable for the twelve months ending June 30, 2025 was $-0.427B, a 30.18% increase year-over-year.
- Quest Diagnostics annual change in accounts receivable for 2024 was $-0.071B, a 373.33% increase from 2023.
- Quest Diagnostics annual change in accounts receivable for 2023 was $-0.015B, a 106.1% decline from 2022.
- Quest Diagnostics annual change in accounts receivable for 2022 was $0.246B, a 203.7% increase from 2021.
Quest Diagnostics Annual Change in Accounts Receivable
(Millions of US $) |
| 2024 |
$-71 |
| 2023 |
$-15 |
| 2022 |
$246 |
| 2021 |
$81 |
| 2020 |
$-455 |
| 2019 |
$-63 |
| 2018 |
$-65 |
| 2017 |
$9 |
| 2016 |
$-42 |
| 2015 |
$-262 |
| 2014 |
$-312 |
| 2013 |
$-247 |
| 2012 |
$-243 |
| 2011 |
$-307 |
| 2010 |
$-310 |
| 2009 |
$-314 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$20.544B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
